本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
BEIJING, April 4, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a manufacturer of ecological environment protection equipment and intelligent equipment in China, today announced that it received a letter, dated March 28, 2025 (the "Letter"), from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the Nasdaq Hearings Panel has concluded that the Company has regained compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Letter stated that the Company will remain on a Discretionary Panel Monitor, pursuant to Listing Rule 5815(d)(4)(A), for a one-year period from the date of the Letter. About ReTo Eco-Solutions, Inc. Founded in 1999, ReTo Eco-Solutions, Inc., through its operating subsidiaries in China, is engaged in the research and development, manufacture and sales of ecological environment protection equipment and intelligent equipment. The Company provides consultation, design, implementation and installation of its equipment and related parts, as well as engineering support and technical advice and services. For more information, please visit: http://en.retoeco.com. For more information, please contact: ReTo Eco-Solutions, Inc.Tel: +86-010-64827328Email: ir@retoeco.com or 310@reit.cc
FORNEBU, Norway, April 3, 2025 /PRNewswire/ -- Aker Horizons ASA (the "Company") hereby publishes its Annual Report 2024, which comprises the Board of Directors' Report including the Sustainability Statement, the consolidated accounts, parent company accounts and the Auditor's Report. In addition, the Company presents its Corporate Governance Report, its Remuneration Report and its Transparency Act Statement for 2024. The reports are attached and are also available on www.akerhorizons.com/investors/reports-and-presentations/. The Company has also published its annual financial statements in European Single Electronic Format (ESEF), available as an attachment to this release. For further information:Investor Relations:Jonas GamreMobile: +47 97 11 82 92E-mail: jonas.gamre@akerhorizons.com Media:Mats Ektvedt,Mobile: +47 41 42 33 28E-mail: mats.ektvedt@corporatecommunications.no About Aker Horizons ASA Aker Horizons ASA develops green energy and green industry to accelerate the transition to Net Zero. The company is active in renewable energy, carbon capture and sustainable industrial assets. As part of the Aker group, Aker Horizons ASA applies industrial, technological and capital markets expertise with a planet-positive purpose to drive decarbonization globally. Aker Horizons ASA is listed on the Oslo Stock Exchange and headquartered in Fornebu, Norway. Across its portfolio, the company is present on five continents. www.akerhorizons.com This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This information was brought to you by Cision http://news.cision.com https://news.cision.com/aker-horizons/r/aker-horizons-asa--annual-report-2024,c4130793 The following files are available for download: https://mb.cision.com/Main/20659/4130793/3367295.pdf Aker_Horizons_Annual_Report_2024 https://mb.cision.com/Main/20659/4130793/3367296.zip ah-2024-12-31-en.zip https://mb.cision.com/Public/20659/4130793/bea8551b2f905efc.pdf Aker Horizons Corporate Governance Report 2024 https://mb.cision.com/Public/20659/4130793/82b382d346913cf8.pdf Aker Horizons Remuneration Report 2024 https://mb.cision.com/Public/20659/4130793/a9ac00ffb2059399.pdf Aker Horizons Transparency Act Statement 2024
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 2, 2025 /PRNewswire/ -- Equity Insider News Commentary – Artificial Intelligence (AI) is quickly becoming a major force in healthcare, as use of AI applications in medical fields is growing rapidly. Researchers at Dartmouth recently conducted the first clinical trial of a therapy chatbot powered by generative AI (genAI), and found that it resulted in significant improvements in participants' symptoms. Cleveland Clinic and UAE-based G42 recently started collaborating on the advancement of even more AI in healthcare adoption, signalling an international push in this revolution. Because of this, the market is paying even more attention to developers in tech that are adding tools to the mix, with recent updates coming from Avant Technologies, Inc. (OTCQB: AVAI), Apple Inc. (NASDAQ: AAPL), Amazon.com, Inc. (NASDAQ: AMZN), Spectral AI, Inc. (NASDAQ: MDAI), and GE HealthCare Technologies Inc. (NASDAQ: GEHC). The article continued: Billionaire Bill Gates recently predicted that he thinks AI will make medical advice free and commonplace, changing healthcare at a rapid pace along the way. Private company Layer Health just raised a fresh $21 million to take on Healthcare AI's scalability challenges, with investment from Define Ventures, Flare Capital Partners, GV and MultiCare Capital Partners. Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City Avant Technologies, Inc. (OTCQB: AVAI), an emerging leader in AI-driven healthcare innovation, continues to build momentum in the AI-driven healthcare sector through its joint venture with Ainnova Tech, developers of the Vision AI platform. Today, the two companies announced that Ainnova will sponsor and present at the 2025 Mexico Healthcare Innovation Summit—an international event focused on digital transformation and diagnostics. Ainnova's CEO, Vinicio Vargas, will present on preventative healthcare powered by artificial intelligence, highlighting the practical impact of its Vision AI platform on early disease detection, which the company recently began designing the clinical trial protocols for ahead of a pre-submission meeting with the US Food and Drug Administration (FDA). Vargas's appearance at the event reinforces a consistent strategy for Avant and Ainnova: increasing visibility across key international markets ahead of major regulatory milestones to come. It also follows Ainnova's recent strategic alignment with Apollo Hospitals in Southeast Asia, where the Vision AI platform has been cleared for commercial deployment in Brazil, and clinical pilots are being prepared across the Americas. As previously mentiond, Ainnova is being guided by global CRO Fortrea ahead of the important pre-submission meeting with the FDA. The goal is to seek 510(k) clearance for Vision AI in detecting diabetic retinopathy, a gateway to broader use across multiple chronic disease categories. Avant and Ainnova jointly control Ai-nova Acquisition Corp. (AAC), which holds global licensing rights to the technology portfolio, including proprietary retinal cameras and algorithms validated on more than 2.3 million clinical data points. Between FDA progress, high-profile alliances, and a growing international presence, Avant Technologies continues to carve out a niche in the convergence of AI, diagnostics, and preventative care. Investors looking for small-cap exposure to the healthcare AI revolution may want to keep AVAI on the radar as these developments unfold. CONTINUED... Read this and more news for Avant Technologies at: https://equity-insider.com/2025/03/21/unlocking-the-trillion-dollar-ai-market-what-investors- need-to-know/ Apple Inc. (NASDAQ: AAPL) is reportedly working on an AI-driven health coach, under the codename Project Mulberry, as a revamped version of its Health app. For a while now, CEO Tim Cook has been promising that Apple's long-term plans include a big push into more health-related technologies. According to Bloomberg's Mark Gurman, Apple could launch this as early as next year alongside a future iOS update. The service would give users tips on diet and exercise, using data from the Health app and Apple devices like the Apple Watch. It's still unclear whether this tool will act more like a real medical assistant or just a health and wellness coach. Gurman describes it as an "AI doctor service," and the report says it's being trained using real data from doctors and medical professionals. The service might be called Health Plus and could become a major part of Apple's growing services business. Amazon.com, Inc. (NASDAQ: AMZN) is pushing deeper into genAI itself, including testing health assistants with a chatbot tool focused on health and wellness, called Health AI, which can answer health and wellness questions, "provide common care options for health care needs," and suggest products. Already, Amazon's shopping chatbot, Rufus, can suggest products like ice packs and ibuprofen. Where Health AI goes further will be in providing users with medical guidance and care tips, such as how to deal with flu or cold symptoms. Health AI also steers users to Amazon's online pharmacy, along with clinical services offered by One Medical, the primary care provider it acquired for roughly $3.9 billion in 2022. Spectral AI, Inc. (NASDAQ: MDAI) recently announced strong results from its Burn Validation Study, showing that its DeepView® System outperformed burn physicians in identifying non-healing tissue. "We believe these are excellent results and we are thrilled with the analysis of our DeepView System in our Burn Validation Study," said Dr J. Michael DiMaio, M.D. "The DeepView System exceeded our expectations in terms of predictive performance. Following the FDA's review, if authorized by the agency, our hope is that this tool will provide an objective and immediate prediction of non-healing burn tissue to expedite patient care and reduce system costs across the board. We look forward to bringing this predictive diagnostic tool to the United States marketplace as soon as possible." The study, one of the largest of its kind in the U.S., demonstrated DeepView's superior accuracy using AI and multispectral imaging to assess burn wounds on day one. The company plans to submit the data to the FDA by mid-2025, aiming for De Novo Clearance and rapid commercialization. GE HealthCare Technologies Inc. (NASDAQ: GEHC) recently unveiled its new Revolution™ Vibe CT system, featuring advanced AI-powered cardiac imaging that delivers fast, accurate scans—even in complex cases like atrial fibrillation or heavy coronary calcification. The system's Unlimited One-Beat Cardiac imaging and AI-driven workflow aim to improve diagnostic speed, patient comfort, and operational efficiency across healthcare facilities. "Expanding access to CCTA is crucial for managing the rising prevalence of CVD, ensuring timely and accurate diagnoses for a larger patient population," shares Jean-Luc Procaccini, President and CEO, Molecular Imaging and Computed Tomography, GE HealthCare. "Our introduction of Revolution Vibe underscores our commitment to this mission. The system is designed to encourage the broader adoption of and access to cardiac imaging, combining advanced technology with AI-powered solutions to deliver fast, accurate diagnoses and a more comfortable patient experience. It is designed to empower healthcare providers to offer the highest quality care, even in the most challenging cases." With FDA-recommended CCTA adoption on the rise and cardiac disease still the leading global cause of death, Revolution Vibe is designed to expand access to life-saving imaging and reduce reliance on invasive procedures. Source: https://equity-insider.com/2025/03/21/unlocking-the-trillion-dollar-ai-market-what-investors- need-to-know/ CONTACT:Equity Insiderinfo@equity-insider.com(604) 265-2873 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
This recent upgrade enables TEPCO Power Grid, Inc. (TEPCO PG) to use the smart meter as a communication hub for other devices TOKYO, April 2, 2025 /PRNewswire/ -- Landis+Gyr (SIX: LAND) announced completion of upgrades to the utility's Advanced Metering Infrastructure (AMI) for electric metering that enable smart meters to act as a communication hub connecting gas and water meters, EV chargers, battery storage and solar panel inverters to the AMI network. TEPCO PG and Landis+Gyr have worked closely to bring these major upgrades to the system, including the full migration of the system onto new virtualized IT infrastructure without disrupting services to numerous retail utilities. These retail utilities receive meter readings every 30 minutes from TEPCO PG to accurately forecast energy demands. The firmware upgrades will allow DERMS providers and asset owners to meter other assets, including distributed energy resources (DERs) across TEPCO PG's distribution network. Additionally, it will allow DERMS providers and asset owners to control such assets through TEPCO PG's AMI while maintaining security and privacy. The new system employs standards-based open technology called Wi-SUN Enhanced HAN, which allows device and communication module providers to participate in the ecosystem with minimum investment. This is one of the first commercial applications of this standard globally. Moving forward, Landis+Gyr will continue to work with TEPCO PG to transition to a next generation AMI system. The companies intend to collaborate closely on a system-wide upgrade to a Wi-SUN FAN and cellular-based network, resulting in a standards-based, open technology. The project will add more bandwidth and flexibility to the system, unleashing the full capability of Wi-SUN and increase interoperability with other technologies, while lowering costs and encouraging innovation. The expanded product ecosystem that results will accelerate the path toward a smart energy future while enhancing the largest AMI/IoT platform in the world. About Landis+GyrLandis+Gyr is a leading global provider of integrated energy management solutions. We measure and analyze energy utilization to generate empowering analytics for smart grid and infrastructure management, enabling utilities and consumers to reduce energy consumption. Our innovative and proven portfolio of software, services and intelligent sensor technology is a key driver to decarbonize the grid. Having avoided around 9 million tons of CO2 in FY 2023, Landis+Gyr manages energy better – since 1896. With sales of USD 2.0 billion in FY 2023, Landis+Gyr employs around 6,700 talented people across five continents. For more information, please visit our website www.landisgyr.com.
HONG KONG and SHANGHAI, April 2, 2025 /PRNewswire/ -- On 1 April 2025, Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group") held its 2024 annual results presentation in Shanghai. The results presentation was attended by Guo Guangchang, Chairman of Fosun International, Wang Qunbin, Co-Chairman of Fosun International, Chen Qiyu and Xu Xiaoliang, Co-CEOs of Fosun International, Gong Ping, CFO of Fosun International, and a number of institutional investors and analysts. In 2024, Fosun International achieved total revenue of RMB192.14 billion, with industrial operation profit, a key indicator for corporate operational performance, reaching RMB4.9 billion; overseas revenue proportion increased from 45% to 49.3%. During the reporting period, loss attributable to owners of the parent amounted to approximately RMB4.35 billion, mainly due to a non-cash impairment loss related to the Cainiao investment. Fosun's investment in Cainiao was approximately RMB1.5 billion and the proceeds from divestments reached approximately RMB4.4 billion, yielding an internal rate of return of approximately 34%. Excluding the effect of the carrying value adjustment, the profit attributable to owners of the parent in 2024 amounted to RMB750 million. Addressing investors' concerns about profitability, Guo Guangchang, Chairman of Fosun International, responded at the results presentation that the financial adjustment in 2024 is not due to Fosun's poor operations or decline in market competitiveness, but rather a one-off carrying value adjustment. Nonetheless, Fosun's operations remain stable and its core businesses are under healthy development, and Fosun's industrial operation profit and operating cash flows stay healthy and stable. Management must remain committed and work diligently to maintain the Company's steady development in the future. In 2024, Fosun had been advancing the business streamlining strategy and pursuing "strategic advancements and exits, and balanced investment and divestment". Wang Qunbin, Co-Chairman of Fosun International, stated, in 2024, Fosun divested from some asset-heavy projects and non-core operations, and leveraged industries where it holds competitive advantages, such as biopharmaceuticals, and tourism and culture. Fosun steadily intensified efforts in implementing the asset-light strategy and collaborating with key partners. This includes the establishment of a biopharmaceutical industry fund in Shenzhen, the Taicang Alps Resort Phase II project, Fosun Tourism Group's launch of Club Med in Jinsha Bay in Shenzhen, the ULTRAMED Hainan project in Sanya, further enhancing Fosun's asset-light operational capabilities to unlock greater project value. Regarding Fosun's innovation strategy, Chen Qiyu, Co-CEO of Fosun International, stated that Fosun has consistently increased its investment in innovation for more than 30 years since its establishment, with investment in technology innovation reaching approximately RMB6.9 billion in 2024. Fosun places significant emphasis on multi-dimensional innovation across various fields, including the development of blockbuster products, product iteration, and customer service. For example, in the consumer business, Fosun has deeply integrated new products with new scenarios through technology innovation; in the insurance business, it has actively promoted the application of technologies such as big data and AI. Biopharmaceuticals are among the most valuable fields for the application of AI technology, where AI has become a key focus in drug R&D, clinical applications, medical imaging and other more. Fosun Pharma has been dedicated to AI-based drug R&D for three years and has achieved notable results, with AI-designed drugs now entering the clinical trial stage. In addition, Fosun Pharma is developing the PharmAID decision intelligence platform, which aims to optimize the innovative R&D process, improve R&D efficiency, and support a more scientific decision-making system. Henlius is the core company for Fosun's innovative drug R&D. Guo Guangchang said, "Henlius is one of Fosun's most promising companies with the greatest potential, and we are optimistic about its potential to achieve product sales of USD10 billion in the future. It represents the future 'Mount Everest' of Fosun, symbolizing its most strategic advantages, and we will provide full support for its development. Fosun has always placed a strong emphasis on innovation, as well as on companies and products with significant growth potential. In our approach to 'strategic advancements and exits', we aim to divest from asset-heavy projects and non-core operations, while pursuing advancements in innovative industries that offer immense potential and vast opportunities." Globalization is a core strategy of Fosun. Guo Guangchang noted that geopolitics affects all companies, and there is no escaping it. The key lies in how a company responds. The best approach is to develop globalization capabilities. For more than ten years, Fosun has consistently focused on building globalization capabilities, and today Fosun is increasingly reaping the rewards. On the one hand, Fosun's globalization strategy promotes Chinese companies and advantageous industries to go global. On the other hand, it helps Fosun's overseas companies expand globally. For example, Fosun Insurance Portugal currently has 29.8% of its income from markets outside Portugal, with international business profits contributing over 50%. Xu Xiaoliang, Co-CEO of Fosun International, stated that since 2008, Fosun has established a business presence in 35 countries and regions around the world. Today, it has evolved from building a global presence to deepening its global operations. With the global presence established, operations have become the core focus for Fosun, and it aims to build global operational capabilities. First, it aims to strengthen its capabilities for global resource integration. For example, Fosun Pharma has been closely collaborating with some of the world's leading institutions in R&D, while integrating the production supply chains from countries and regions such as India and Africa. In 2024, Fosun Pharma's overseas revenue reached RMB11.3 billion, accounting for 27% of its total revenue, positioning it among the leaders in global integration capabilities within Chinese pharmaceutical companies. Second, it aims to enhance its capabilities for global expansion and presence. For example, Fosun Insurance Portugal has been expanding its business overseas and has achieved rapid growth in Portuguese-speaking countries such as Bolivia, Peru, and Angola and Mozambique in Africa. Third, it aims to strengthen its capabilities for localization integration. For example, Club Med under Fosun Tourism Group, has innovated products such as Urban Oasis and Joyview in China, focusing on urban vacations and ice and snow vacations, thereby effectively combining and integrating the global model into the Chinese local market. In discussing Fosun's future goals, Guo Guangchang said that Fosun will continue to divest from some asset-heavy projects to reduce financial leverage and maintain "strategic advancements and exits, and balanced investment and divestment", while deepening its industry operations. In 2024, Fosun's industrial operation profit amounted to approximately RMB4.9 billion, and the Company aims to double it to reach RMB10 billion in the future. Achieving this goal will require sustained efforts to drive growth in operating profits, and it is a target that we can strive for and anticipate. Gong Ping, CFO of Fosun International, stated that Fosun's management is confident in Fosun's net profit for 2025 and is committed to steadily enhancing profitability in the future. In the next few years, the Group aims to gradually increase the proportion of overseas revenue in its global operations; progressively reduce the Group's interest-bearing debts from the current level of more than RMB80 billion to RMB60 billion; and strive to achieve RMB10 billion in industrial operation profit as well as in profit attributable to owners of the parent; work towards gradually increasing the dividend payout ratio, endeavoring to attain "investment grade" credit ratings. "The process of Fosun's strategic adjustments is not easy. It requires strategic determination and time to do it step by step. Fosun has always persisted in doing the right things, difficult things and things that take time to develop, and we remain dedicated to this commitment," said Guo Guangchang.
Report to be released at approximately 7:00 AM CEST on April 15, 2025 One live video webcast for analysts, investors and journalists at 9:00 AM CEST STOCKHOLM, April 1, 2025 /PRNewswire/ -- Ericsson's (NASDAQ: ERIC) financial report for the first quarter 2025 will be published at approximately 7:00 AM CEST on April 15, 2025. The company will issue a press release with the complete financial report attached, including tables, in PDF format. Following publication of the press release, the financial report will be available on Ericsson's website: www.ericsson.com/en/investors/financial-reports/interim-reports President and CEO Börje Ekholm and CFO Lars Sandström will comment on the report and take questions at a live video webcast at 9:00 AM CEST (8:00 AM BST London, 3:00 AM EDT New York). Join the webcast or please go to www.ericsson.com/investors To ask a question: Access dial-in information here The webcast will be available on-demand after the event and can be viewed on our website. NOTES TO EDITORS: FOLLOW US: Subscribe to Ericsson press releases hereSubscribe to Ericsson blog posts herehttps://twitter.com/ericssonhttps://www.facebook.com/ericssonhttps://www.linkedin.com/company/ericsson MORE INFORMATION AT:Ericsson Newsroommedia.relations@ericsson.com (+46 10 719 69 92)investor.relations@ericsson.com (+46 10 719 00 00) ABOUT ERICSSON:Ericsson's high-performing networks provide connectivity for billions of people every day. For nearly 150 years, we've been pioneers in creating technology for communication. We offer mobile communication and connectivity solutions for service providers and enterprises. Together with our customers and partners, we make the digital world of tomorrow a reality. www.ericsson.com This information was brought to you by Cision http://news.cision.com https://news.cision.com/ericsson/r/invitation-to-media-and-analyst-briefing-for-ericsson-q1-2025-report,c4128145 The following files are available for download: https://mb.cision.com/Main/15448/4128145/3357255.pdf Invitation to media and analyst briefing for Ericsson Q1 2025 report
OTC/Small Cap
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
